Erica Cerutti

‘Bigger than politics’: Former surgeons general warn of instability at HHS

10/07/2025

A bipartisan group of former U.S. surgeons general expressed significant concern in HHS Secretary Robert F. Kennedy Jr.’s leadership in a joint op-ed published Oct. 7 in The Washington Post. The former surgeons general — who collectively served under every president since George H.W. Bush — claim Mr. Kennedy’s actions…

10 safest US states

10/06/2025

Vermont ranks as the safest state in the U.S., based on neighborhood safety, a low unemployment rate and safe roads, according to an Oct. 6 ranking from WalletHub. Nearly 3 in 4 parents in Vermont said they live in safe neighborhoods — the fourth-highest share in the U.S. The state…

Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test

10/06/2025

-Only MCED test on-market to analyze multiple biomarker classes, enhancing early cancer detection-Offered as a laboratory-developed test at $689-Nationwide access enabled through Quest Diagnostics’ 7,000 patient access sites MADISON, Wis., September 10, 2025 — Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer diagnostics, today announced the launch of the Cancerguard™…

How to Achieve Short-Term Workforce Stability While Executing a Long-Term Strategy

09/30/2025

By 2037, the National Center for Health Workforce Analysis projects a shortfall of more than 187,000 physicians across 31 of 35 specialties, including notable gaps in anesthesia, obstetrics and gynecology, and radiology. As physician shortages intensify in the years ahead, healthcare leaders are being asked to address two challenges simultaneously:…

The hidden costs of inventory: How health systems can drive savings + resilience

09/30/2025

Healthcare supply chains are under immense pressure, and the stakes in 2025 are higher than ever. Policy shifts, rising costs and tariff implications are compounding long-standing challenges around inventory management. For hospitals and health systems, this creates a delicate balancing act: clinical and pharmacy leaders must ensure uninterrupted access to…

FDA approves breast cancer drug

09/26/2025

The FDA has approved Eli Lilly’s imlunestrant, an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer that has progressed following at least one prior endocrine therapy.  The approval is based on results from a phase 3 trial, which…

Severe pediatric flu complication on the rise, CDC data suggests

09/26/2025

Cases of a rare, flu-related complication that causes brain inflammation among children are on the rise, a new CDC report suggests. During the 2024-25 flu season, 109 children were diagnosed with influenza-associated encephalopathy, according to the report, which is based on cases clinicians and health departments confirmed with the CDC.…